share_log

CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gumulka Jerzy

SEC ·  Feb 6 09:32
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more